Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide activates two separate appetite-regulating pathways in your brainGLP-1 and GIP receptorsmaking it roughly 25% more effective than single-pathway GLP-1 drugs for weight reduction
The biochemical pathways don't overlap
Your cells build it from three amino acids: glutamine, glycine, and cysteine
Metabolic rate elevated
Whilst injections bypass gut absorption, conditions like active Crohn's disease or coeliac disease may cause increased metabolic demands that could influence how quickly B12 is utilised
Research shows that metformin and tirzepatide have complementary mechanismsmetformin reduces liver glucose production while tirzepatide increases insulin secretion and slows digestionmaking them candidates for combined use under medical supervision
